Related Experiment Video
Updated: Aug 12, 2025

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Respiratory insufficiency as a presenting symptom of congenital myasthenic syndromes
Fleur van den Udenhout1, Peter Merkus2, Sandra Verhaagen-van den Akker3
1Department of Paediatric Neurology, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, Netherlands.
Insights
Congenital myasthenic syndromes (CMS) can cause respiratory insufficiency in children. Early diagnosis and treatment with pyridostigmine can improve outcomes for affected infants and children.
Area of Science:
- Pediatric Neurology
- Rare Genetic Disorders
- Respiratory Medicine
Background:
- Congenital myasthenic syndromes (CMS) are rare genetic disorders affecting neuromuscular transmission.
- Respiratory insufficiency is an underrecognized presenting symptom of CMS in pediatric patients.
Purpose of the Study:
- To increase pediatrician awareness of CMS as a cause of respiratory insufficiency in children.
- To highlight the importance of early diagnosis and treatment for CMS.
Main Methods:
- Retrospective case study of five infants and preschool children.
- Patients presented with respiratory insufficiency as the primary symptom of CMS.
- Genetic confirmation of CMS and assessment of treatment response.
Main Results:
- Five children aged 2 weeks to 5 years experienced severe respiratory insufficiency, often exacerbated by viral infections.
- Patients exhibited progressive muscle weakness, particularly during infections.
- Treatment with pyridostigmine led to clinical improvement in all five children.
Conclusions:
- CMS should be considered in pediatric patients with unexplained recurrent respiratory insufficiency or severe respiratory infections.
- Early diagnosis of CMS is critical to prevent sudden infant death and long-term muscle weakness.
- Prompt treatment can significantly improve clinical outcomes for children with CMS.
Aim:
Respiratory insufficiency can be a presenting symptom of congenital myasthenic syndromes (CMS) but is rarely recognised as such. In this study, we aim to raise awareness of CMS to paediatricians.
Methods:
We performed a retrospective case study of infants and preschool children treated in the past 5 years in Amalia Children's Hospital, Radboud University Medical Center in Nijmegen, the Netherlands for respiratory insufficiency as presenting symptom of CMS.
Results:
Five children aged 2 weeks to 5 years experienced severe to life-threatening episodes of respiratory insufficiency, especially during viral infections, due to respiratory muscle weakness. During infections, they often also had progression of their otherwise mild ocular, facial, and limb muscle weakness. They were eventually diagnosed with genetically proven CMS. In these five children, treatment with pyridostigmine, an acetylcholinesterase inhibitor, resulted in clinical improvement.
Conclusion:
CMS should be considered in every patient with unexplained recurrent respiratory insufficiency, or with an unusually severe course of a normally mild respiratory infection, especially in combination with mild muscle weakness outside periods of illness. Early diagnosis of CMS is crucial for early treatment, which may help avoiding sudden infant death, severe respiratory insufficiency and further deterioration of the muscle strength.
More Related Videos
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Acute Respiratory Failure-IV
Respiratory System Abnormal Finding I: Inspection and Percussion
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Breathing
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration...

